Try our beta test site
75 studies found for:    Open Studies | "Hypercholesterolemia"
Show Display Options
Rank Status Study
21 Not yet recruiting A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients
Condition: Hypercholesterolemia
Intervention: Drug: DW-3102
22 Recruiting A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Ezetimibe
23 Recruiting Graves' Orbitopathy and Hypercholesterolemia
Conditions: Graves' Ophthalmopathy;   Hypercholesterolemia
Intervention: Other: No intervention
24 Recruiting Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)
Condition: Hypercholesteremia
Interventions: Drug: Gemcabene 300 mg;   Drug: Gemcabene 600 mg;   Drug: Gemcabene 900 mg
25 Recruiting Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
Condition: Hypercholesterolemia
Interventions: Drug: Praluent (Alirocumab);   Drug: Placebo
26 Recruiting To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
Condition: Severe Hypercholesterolemia
Intervention: Drug: Atorvastatin, Probucol, Cilostazol
27 Recruiting Evaluation of Coronary Artery Plaque Volume Progression/Regression and Safety of Alirocumab in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Conditions: Hypercholesterolemia;   Acute Coronary Syndrome
Interventions: Drug: alirocumab SAR236553;   Drug: atorvastatin;   Drug: rosuvastatin;   Drug: fenofibrate;   Drug: bezafibrate;   Drug: ezetimibe;   Drug: antiplatelets;   Drug: anticoagulants
28 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Subjects With Familial Hypercholesterolemia
Conditions: Hypertriglyceridemia;   Familial Hypercholesterolemia
Interventions: Drug: IONIS ANGPTL3-LRx;   Drug: Placebo (0.9%NaCl, water, riboflavin)
29 Not yet recruiting Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Conditions: Type 1 Diabetes;   Familial Hypercholesterolemia
Intervention:
30 Recruiting A Study in Subjects With Type 2 Diabetes Mellitus With Hypercholesterolemia/Mixed Dyslipidemia
Conditions: Hypercholesterolemia;   Mixed Dyslipidemia;   Type 2 Diabetes
Interventions: Biological: Evolocumab;   Other: Placebo to Evolocumab
31 Recruiting Chart Review of Repatha® in Subjects With Hyperlipidaemia
Condition: Hypercholesterolaemia
Intervention:
32 Recruiting Familial Hypercholesterolemia Amongst Patients With Acute Coronary Syndrome
Conditions: Familial Hypercholesterolemia;   Cardiac Event;   Acute Coronary Syndrome
Intervention: Other: Registry
33 Recruiting Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4
Condition: Hypercholesterolemia
Interventions: Biological: Evolocumab;   Drug: Ezetimibe
34 Not yet recruiting Lp(a) and Aortic Valve Calcification
Condition: Heterozygous Familial Hypercholesterolemia
Intervention:
35 Recruiting Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
Condition: Hypercholesterolemia
Interventions: Drug: Bempedoic acid 180mg;   Drug: Ezetimibe 10mg;   Drug: Atorvastatin 20mg;   Other: Placebo
36 Recruiting A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects
Condition: Hypercholesterolemia
Interventions: Drug: alirocumab SAR236553 (REGN727);   Drug: placebo
37 Recruiting Efficacy of a LRC™ (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: LRC™ capsule;   Other: Placebo capsule
38 Recruiting Validating the "Foods for Health" Portfolio of Functional Food Products
Condition: Hypercholesterolemia
Interventions: Other: Portfolio of functional foods;   Other: Control foods
39 Recruiting Evolocumab Pregnancy Exposure Registry
Condition: Hypercholesterolemia; Pregnancy
Intervention: Drug: evolocumab
40 Recruiting Study to Evaluate the Safety of Repatha® in Pregnancy
Conditions: Hypercholesterolaemia;   Pregnancy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.